CONDENSED CONSOLIDATED INTERIM STATEMENTS OF OPERATIONS - USD ($) |
3 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|
May 31, 2026 |
May 31, 2025 |
May 31, 2026 |
May 31, 2025 |
|||
| Operating expenses | ||||||
| Business development | $ 267,827 | $ 348,277 | ||||
| Amortization and depreciation | 5,602 | 8,026 | ||||
| Exploration expense | 496,419 | $ 56,678 | 723,920 | $ 63,983 | ||
| Office and administrative | 831,489 | 60,539 | 1,238,685 | 91,580 | ||
| Professional fees | 2,010,841 | 710,540 | 2,469,761 | 1,213,453 | ||
| Rent expense | 80,856 | 22,483 | 153,598 | 48,943 | ||
| Investor relations | 69,390 | 159,211 | ||||
| Salaries and wages | 3,295,905 | 3,353,846 | ||||
| Licensing fee expense | 12,603 | 26,249 | ||||
| Travel and entertainment | 236,509 | 170,706 | 287,971 | 269,552 | ||
| Total operating expenses | (7,307,441) | (1,020,946) | (8,769,544) | (1,687,511) | ||
| Other income (expense) | ||||||
| Change in fair value of warrant liability | (17,750,724) | (17,750,724) | ||||
| Interest income | 31 | 31 | ||||
| Loss on foreign currency transactions | (3,813) | (4,160) | (13,592) | (4,590) | ||
| Total other expense | (17,754,506) | (4,160) | (17,764,285) | (4,590) | ||
| Net loss | (25,061,947) | (1,025,106) | (26,533,829) | (1,692,101) | ||
| Preferred stock dividends | (748,603) | (781,151) | ||||
| Net loss attributable to common stockholders, basic | (25,810,550) | (1,025,106) | (27,314,980) | (1,692,101) | ||
| Net loss attributable to common stockholders, diluted | $ (25,810,550) | $ (1,025,106) | $ (27,314,980) | $ (1,692,101) | ||
| Weighted average number of shares outstanding, common stock - Basic (in shares) | [1] | 29,657,841 | 17,717,143 | 24,567,206 | 17,252,802 | |
| Weighted average number of shares outstanding, common stock - Diluted (in shares) | [1] | 29,657,841 | 17,717,143 | 24,567,206 | 17,252,802 | |
| Loss per share, common stock - Basic (in dollars per share) | [1] | $ (0.87) | $ (0.06) | $ (1.11) | $ (0.1) | |
| Loss per share, common stock - Diluted (in dollars per share) | [1] | $ (0.87) | $ (0.06) | $ (1.11) | $ (0.1) | |
| ||||||
| X | ||||||||||
- Definition The amount of expense incurred for investor relations during the period. No definition available.
|
| X | ||||||||||
- Definition The amount of expense for license fee. No definition available.
|
| X | ||||||||||
- Definition The expense for managing and administering the affairs of an entity. No definition available.
|
| X | ||||||||||
- Definition The amount of rent expense incurred during the period. No definition available.
|
| X | ||||||||||
- Definition Business development involves the development of products and services, their delivery, design and their implementation. Business development includes a number of techniques designed to grow an economic enterprise. Such techniques include, but are not limited to, assessments of marketing opportunities and target markets, intelligence gathering on customers and competitors, generating leads for possible sales, follow-up sales activity, formal proposal writing and business model design. Business development involves evaluating a business and then realizing its full potential, using such tools as marketing, sales, information management and customer service. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Exploration expenses (including prospecting) related to oil and gas producing entities and would be included in operating expenses of that entity. Costs incurred in identifying areas that may warrant examination and in examining specific areas that are considered to have prospects of containing oil and gas reserves, including costs of drilling exploratory wells and exploratory-type stratigraphic test wells. Exploration costs may be incurred both before acquiring the related property (sometimes referred to in part as prospecting costs) and after acquiring the property. Principal types of exploration costs, which include depreciation and applicable operating costs of support equipment and facilities and other costs of exploration activities, are: (i) Costs of topographical, geographical and geophysical studies, rights of access to properties to conduct those studies, and salaries and other expenses of geologists, geophysical crews, and others conducting those studies. Collectively, these are sometimes referred to as geological and geophysical or "G&G" costs. (ii) Costs of carrying and retaining undeveloped properties, such as delay rentals, ad valorem taxes on properties, legal costs for title defense, and the maintenance of land and lease records. (iii) Dry hole contributions and bottom hole contributions. (iv) Costs of drilling and equipping exploratory wells. (v) Costs of drilling exploratory-type stratigraphic test wells. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Expenses incurred for travel and entertainment during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|